What actually makes a good weight loss injection?

The biggest myth first: 'stronger' and 'better' are not the same thing

A common assumption is that whichever injection produces the highest average weight loss in a trial must be the right choice for everyone. The reality is more nuanced. The question of what injection is good for weight loss depends on your health history, any medicines you already take, how you feel about injections versus tablets, and what your prescriber concludes after a proper assessment.

Tirzepatide acts on two receptors simultaneously (GIP and GLP-1) making it the only dual-agonist licensed for weight management in the UK. In the SURMOUNT-1 trial, published in the New England Journal of Medicine, participants on the highest dose saw an average body-weight reduction of around 20–21% over 72 weeks. Semaglutide (Wegovy) activates the GLP-1 receptor alone; the STEP 1 trial recorded approximately 15% average weight reduction over 68 weeks at the standard 2.4mg maintenance dose. A higher 7.2mg dose was approved by the MHRA in January 2026, with trial data showing around 20.7% average loss, which narrows the gap considerably.

The point is not that one is categorically superior. It is that the difference in average outcomes between the two medicines is smaller than the difference between taking either medicine properly and taking it poorly. Thinking about which injection is good for your weight loss, specifically, is a clinical conversation, not a stat comparison.

What the science actually shows about how these injections work

Both medicines slow gastric emptying, meaning food moves through your stomach more gradually. That physical change contributes to the feeling of fullness that most people notice within the first few weeks. Appetite signals from the brain are also affected directly: hunger becomes less insistent, and the drive to eat past comfortable fullness tends to quieten.

This mechanism matters because it explains why the medicines are not simply a shortcut. They work best when the reduced appetite is matched by deliberate choices about protein intake, hydration and some form of regular movement. The NHS patient information for tirzepatide and the equivalent page for semaglutide both outline how the medicine sits alongside lifestyle change rather than replacing it.

Side effects are mostly gastrointestinal (nausea, loose stools, constipation, reflux) and are typically most noticeable after starting or after a dose step up. They tend to settle within days to a couple of weeks for most people. More serious but infrequent reactions include acute pancreatitis: severe stomach pain that spreads to the back, with or without vomiting, needs urgent medical attention. The MHRA issued a formal Drug Safety Update on this in January 2026. If you want a fuller picture of the risk profile, our page on whether weight loss injections are right for you covers this in detail.

Who these injections are actually licensed for (and where cost sits in that picture

Both medicines are licensed for adults with a BMI of 30 or above, or 27 and above where at least one weight-related condition is present) for example, high blood pressure, type 2 diabetes, high cholesterol or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. BMI alone is not a green light; the prescriber's assessment of your full health picture is what determines suitability.

On the NHS, access is phased and criteria are strict. Tirzepatide is being rolled out in cohorts based on BMI and the number of qualifying conditions. Many people turn to a private regulated pharmacy rather than wait, which is where cost becomes relevant. Private pricing varies by dose and provider, and it is worth understanding what a quoted price actually includes before committing. Our guide to weight loss injection costs in the UK sets out the full picture, including what is often missing from the headline figure.

One practical note: orders placed before noon on a weekday (useful to know if you are planning around a payday or a bank holiday) are dispatched the same day once a prescriber has approved them, arriving the next working day via tracked delivery. That timing matters if you are trying to avoid a gap in treatment.

If you are weighing up injections against newer oral options, the comparison is less straightforward than it seems. How tablets compare to injections for weight loss explores what the current evidence shows. For an overview of all licensed options, our weight loss injections page brings together the key facts in one place.

What a genuinely good service around these injections looks like

The injection itself is only part of what makes treatment work. A prescriber who reviews your answers the same day, checks your identity and weight, notifies your GP, and reassesses your case before every repeat order is not a luxury add-on. It is the baseline that UK regulations exist to enforce, and that good clinical practice demands.

Semaglutide is sometimes searched under shortened spellings; if you have come across references to a sematide injection or a semi weight loss injection, these are informal shorthand for semaglutide (Wegovy). The medicine itself is the same; what varies is the quality of the service dispensing it. Verify any online pharmacy on the GPhC register before you share personal or health information with them. A pharmacy you cannot verify there should not be dispensing prescription medicines.

Aftercare matters too. Questions about how you are tolerating the medicine, whether your dose is due for review, or how to handle a missed pen are not edge cases, they come up regularly. Access to a clinician who can answer them is part of what separates a safe course of treatment from an unsupervised one. You can read more about how nume approaches clinical oversight or visit our weight loss injection overview to see the treatment options we offer.